Atricure Inc.

Atricure Inc., a Mason, Ohio-based manufacturer of cardiac ablation devices and surgical consumables, operates as a prime contractor supplying specialized medical devices and surgical equipment to federal healthcare customers—chiefly the Department of Veterans Affairs, the Department of the Navy, and the Army Medical Command—with no subcontract footprint and no set-aside designations across its recent federal work. The company competes exclusively in full-and-open procurements, typically through sole-source purchase orders and task orders under existing blanket purchase agreements where its proprietary ablation systems establish competitive advantage based on compatibility and medical necessity rather than small business status.

Atricure's federal footprint concentrates heavily in VA healthcare networks. The top five customer segments account for 41% of awards by count, led by the Department of the Navy Bureau of Medicine and Surgery (59 awards, $635 thousand combined potential value), Veterans Integrated Service Network 17 (49 awards, $864 thousand), and Veterans Integrated Service Network 8 (39 awards, $635 thousand). By dollar volume, the rankings shift: the Department of the Army Medical Command carries the largest single-agency exposure at $1.1 million across eight awards, followed by VISN 17 and the Navy. The total addressable federal market captured is modest—$8.8 million combined potential value across 488 awards—reflecting the transactional nature of medical device supply orders; obligated dollars reach $7.1 million (80% of potential value), signaling reliable contract execution and payment.

Recent named awards illustrate the core capability: a $100,350 purchase order from VA VISN 19 in February 2026 for cardiac ablation surgical consumables including Isolator Synergy Clamps, Pen Ablation Isolator devices, EPI-Sense ST coagulation devices, and related ablation systems; a $66,000 purchase order from VA VISN 19 in May 2026 for AtriClip PRO-V Clips (four surgical clip variants); and a $295,770 BPA call award from VA VISN 16 in April 2022 for ablation consumables and systems running through March 31, 2027. Atricure holds a primary single-award Blanket Purchase Agreement with VA VISN 16 (BPA 36C25622A0021, ceiling $472,476, extended through March 31, 2027), which serves as the parent vehicle for four task orders totaling $296 thousand in combined potential value. Recent activity spans 2022 through May 2026, with award volume declining from five awards in 2022 to two in 2024 and three in 2026, suggesting contract consolidation rather than growth. Two awards (combined potential value $296 thousand) complete within the next twenty-four months, representing the recompete exposure window.

Work is performed directly at Atricure's Mason, Ohio facility without subcontractors, across 22 distinct federal customer agencies in full-and-open competition. NAICS concentration sits in surgical and medical instrument manufacturing (254 awards) and surgical appliance and supplies manufacturing (44 awards); PSC coding is dominated by 6515 (Medical and Surgical Instruments, Equipment, and Supplies), covering 470 of 488 awards. The company supplies no services, systems integration, or professional labor—only medical device consumables and small surgical instruments—and operates in an exclusively federal market where product compatibility, regulatory clearance, and established medical protocols create high barriers to competitive substitution.